Creatd receives Nasdaq delisting notice for failure to meet market value of listed securities

Creatd, Inc.

Nasdaq notified Creatd on March 1, 2022 of delisting determination for non-compliance with Listing Rule 5550(b)(2) for 30 consecutive days ending Feb 25, 2022.
Company is ineligible for 180-day cure period due to existing Panel Monitor from March 2021 to March 2022.
Creatd is appealing to the Nasdaq Hearings Panel; delisting is stayed pending the Panel's decision.
Company intends to present evidence of regained compliance, but no assurance of continued listing.
Delisting notice does not immediately affect trading of common stock (CRTD) or warrants (CRTDW).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.